Patents matching “antagonist”

US 7176211

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Feb 13, 2007 · Expires Feb 8, 2027

US 7173005

Insulin and IGF-1 receptor agonists and antagonists

ANTYRA INC. · Granted Feb 6, 2007 · Expires Feb 1, 2027

US 7163934

Methods for treating delirium glucocorticoid receptor-specific antagonists

Corcept Therapeutics Incorporated · Granted Jan 16, 2007 · Expires Jan 11, 2027

US 7151115

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Dec 19, 2006 · Expires Dec 14, 2026

US 7150871

Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6

The Regents of the University of California · Granted Dec 19, 2006 · Expires Dec 14, 2026

US 7115560

Methods for modulating gastric secretion using prokineticin receptor antagonists

The Regents of the University of California · Granted Oct 3, 2006 · Expires Sep 28, 2026

US 7105488

G protein-coupled receptor antagonists

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7081459

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Jul 25, 2006 · Expires Jul 20, 2026

US 7071200

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Jul 4, 2006 · Expires Jun 29, 2026

US 7071224

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Jul 4, 2006 · Expires Jun 29, 2026

US 7064112

Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

CAN-FITE BIOPHARMA LTD. · Granted Jun 20, 2006 · Expires Jun 15, 2026

US 7056500

Polymer conjugates of opioid antagonists

Nektar Therapeutics AL, Corporation · Granted Jun 6, 2006 · Expires Jun 1, 2026

US 7056927

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Jun 6, 2006 · Expires Jun 1, 2026

US 7037916

Pyrimidine derivatives as IL-8 receptor antagonists

Pharmacopeia Drug Discovery, Inc. · Granted May 2, 2006 · Expires Apr 27, 2026

US 7015226

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Mar 21, 2006 · Expires Mar 16, 2026

US 6964953

Methods for treating stress disorders using glucocorticoid receptor-specific antagonists

Corcept Therapeutics Incorporated · Granted Nov 15, 2005 · Expires Nov 10, 2025

US 6953779

Melanocortin receptor antagonists and modulations of melanocortin receptor activity

The Regents of the University of California · Granted Oct 11, 2005 · Expires Oct 6, 2025

US 6951858

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Oct 4, 2005 · Expires Sep 29, 2025

US 6939883

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Sep 6, 2005 · Expires Sep 1, 2025

US 6930185

Melanin-concentrating hormone antagonist

Takeda Chemical Industries Ltd. · Granted Aug 16, 2005 · Expires Aug 11, 2025

US 6921761

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Jul 26, 2005 · Expires Jul 21, 2025

US 6919347

Bradykinin B1 receptor antagonists

Pharmacopeia Drug Discovery, Inc. · Granted Jul 19, 2005 · Expires Jul 14, 2025

US 6903131

3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists

Pharmacopeia Drug Discovery, Inc. · Granted Jun 7, 2005 · Expires Jun 2, 2025

US 6890738

Prolactin antagonists and uses thereof

The Regents of the University of California · Granted May 10, 2005 · Expires May 5, 2025